Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
4-AcO-MET
Pregabalin
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Paradise island by Xanny.jpgParadise island by Subsentience
Methallylescaline
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Efavirenz
Experience:1mg 25c-NBOMe - Experiment in my room
25C-NBOMe
Piracetam
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Experience:1000 Morning Glory seeds - Rediscovering the Self
4-HO-MiPT
THJ-018
5-MeO-DiBF
Selective serotonin reuptake inhibitor
6-APDB
Experience:120mg - Garden of The Gods
ETH-LAD
Proscaline
Psilocybin mushrooms
PRO-LAD
DET
MET
Experience:3g mimosa / 3g syrian rue - Connecting with my body
4-AcO-DMT
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Pramiracetam
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
Experience:250mg DXM - DXM Itch and Trip Report
25D-NBOMe
5-MeO-DALT
LSD
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
4-HO-MPT
2C-B-FLY
Chur City in Switzerland.jpgChur, Switzerland by Naps284
GABAergic hallucinogens
Phenethylamine (compound)
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
2C-T-7
LSZ
4-HO-MET
25I-NBOH
25B-NBOH
MiPT
2C-E
5F-PB-22
Cannabis
2C-T-2
25B-NBOMe
1P-LSD
1P-ETH-LAD
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
4-HO-DiPT
Amanita muscaria
DOC
Enhancement of colour rose.jpgRose by Chelsea Morgan
2C-H
2C-D
Omberacetam
DMT
Chameleon.jpgChameleon by Anonymous.
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
MPT
Experience:40mg - Brothermind and the Forest's Hand
Allylescaline
ALD-52
Experience:3-MeO-PCP - Extreme psychosis
MDAI
25C-NBOH
DOI
4-AcO-MiPT
MDA
MiPLA
LSA
1B-LSD
2C-T-21
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
4-FA
Memantine
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
5-MeO-DiPT
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
2C-C
DiPT
JWH-073
Aniracetam
TMA-2
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
3-MMC
TMA-6
Phenylpiracetam
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
4-HO-DET
JWH-018
DPT
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
AL-LAD
3-MeO-PCE
MDEA
Oxiracetam
Escaline
25I-NBOMe
Psilocin
MDMA
EPT
Βk-2C-B
ΑMT
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
Ayahuasca
6-APB
Experience:4x 200ug tabs - You do not need to understand
Experience:BK-2C-B - Various experiences
Experience:4-HO-MiPT / A care free psychedelic getaway
Experience:800 seeds LSA - My First Trip Ever
DOB
Experience:300µg LSD - Togetherness and the Silent Dusk
Bufotenin
4-AcO-DiPT
25N-NBOMe
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Experience:2 tabs DOB - My DOB Nightmare
LSM-775
Bromo-DragonFLY
PARGY-LAD
Ibogaine
4-HO-EPT
Experience:25mg 3-MeO-PCP - Enhanced film experience
THJ-2201
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Experience:337mg DMT fumarate - A Day With DMT
2C-B
2C-I
2C-P
Tree.jpgJapanese Garden by Anonymous
Experience:4.5g - The Grand Introduction to Beauty and Fear
Mescaline
5-MeO-MiPT
3C-E
5-Hydroxytryptophan
4-HO-DPT
4-AcO-DET

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.